Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
about
Pharmacology of Aldosterone and the Effects of Mineralocorticoid Receptor Blockade on Cardiovascular SystemsPrimary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney.Potential pathophysiological role for the vitamin D deficiency in essential hypertension.Interactions between adrenal-regulatory and calcium-regulatory hormones in human health.Mineral metabolism and outcomes in chronic kidney disease stage 2-4 patients.Left ventricular hypertrophy and chronic renal insufficiency in the elderly.Serum uric acid is associated with left ventricular hypertrophy independent of serum parathyroid hormone in male cardiac patients.Bone mineral metabolism parameters and urinary albumin excretion in a representative US population sampleEstimation of the cutoff value of vitamin D: the Dong-gu studyHypertension, Antihypertensive Medications, and Risk of Incident Primary Hyperparathyroidism.Coronary Microvascular Function and Beyond: The Crosstalk between Hormones, Cytokines, and Neurotransmitters1,25-Dihydroxyvitamin D to PTH(1-84) Ratios Strongly Predict Cardiovascular Death in Heart Failure.A Rare Presentation of Primary Hyperparathyroidism with Concurrent Aldosterone-Producing Adrenal CarcinomaParaneoplastic hypocalcemia-induced heart failure in advanced breast cancer: A case report and literature review.Vitamin D and hypertension: Prospective study and meta-analysis.Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trialRelation of vitamin D and parathyroid hormone to cardiac biomarkers and to left ventricular mass (from the Cardiovascular Health Study)The influence of sodium- and calcium-regulatory hormone interventions on adipocytokines in obesity and diabetesCardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional linksSerum vitamin D and parathyroid hormone in relation to cardiac structure and function: the ICELAND-MI substudy of AGES-Reykjavik.Policosanol as a new inhibitor candidate for vascular calcification in diabetic hyperlipidemic rats.Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.Standardized serum 25-hydroxyvitamin D concentrations are inversely associated with cardiometabolic disease in U.S. adults: a cross-sectional analysis of NHANES, 2001-2010.Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi-Ethnic Study of Atherosclerosis).Cinacalcet hydrochloride for the treatment of hyperparathyroidism.The role of calcium in the prevention of cardiovascular disease--a review of observational studies and randomized clinical trials.Exercise intolerance in chronic heart failure: the role of cortisol and the catabolic state.PTH and Vitamin D.Phosphate imbalance in patients with heart failure.Secondary hyperparathyroidism prevalence and prognostic role in elderly males with heart failure.Low serum 25-hydroxyvitamin D levels and secondary hyperparathyroidism in Fontan patients.Association of serum vitamin D and parathyroid hormone with subclinical atherosclerotic phenotypes: The Dong-gu Study.Relationship between parathyroid hormone and subclinical myocardial dysfunction in patients with severe psoriasis.Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists.Influence of renal impairment on aldosterone status, calcium metabolism, and vasopressin activity in outpatients with systolic heart failure.The predictability of renin-angiotensin-aldosterone system factors for clinical outcome in patients with acute decompensated heart failure.Independent associations of circulating 25-hydroxyvitamin D and parathyroid hormone concentrations with blood pressure among Koreans: The Korea National Health and Nutrition Examination Survey (KNHANES), 2009-2010.Parathyroid hormone, vitamin D levels and urine albumin excretion in older persons: the 2011 Korea National Health and Nutrition Examination Survey (KNHANES).PTH Is a Promising Auxiliary Index for the Clinical Diagnosis of Aldosterone-Producing Adenoma.Is there any association between primary hyperparathyroidism and ocular changes, such as central corneal thickness, retinal thickness, and intraocular pressure?
P2860
Q27010641-254526AC-615C-4998-BA4B-7DB6A244CF64Q30248429-0DD4E71C-BE18-42F8-8150-34B9E2AED618Q30363752-ECA5EEF7-A4F0-495C-BEB9-DBB4844943ABQ34008136-4D76C5CD-977A-4B39-AAAB-DEA680A8FD03Q34550213-6C82E6F4-376E-46BB-8547-4ADA84907ADEQ34985754-AAFE0CE6-91D9-4164-BB17-80C7881A7769Q35067870-974F59FB-B1B5-4603-9A60-29DCF179DBF0Q35088716-5B4F854C-93F3-472F-ABDE-96382B89C1C6Q35177119-3F922791-7243-4C54-AD62-45C722C710D3Q35680906-C2C6DD86-B420-445F-B714-2FF378ACE12DQ35739686-B390D5AC-2E46-4CD0-AE91-5CC13BA2E495Q35755817-794D9E6B-0EA9-4C5E-901E-3DB0651969B5Q35806532-0A6C6C2C-8BE6-47BF-AB71-883EFAAA1B4CQ35871419-4425724C-7A0F-402B-B213-FD88847C91E4Q36328167-984C5597-0431-4A44-803F-13F543FC844AQ36448508-C4D9589D-F235-44B2-8BC4-CF6A6B869B6BQ36536486-D30ABD88-B5AC-4113-9B37-C69AF2CC9F13Q36609595-B6784F5D-4BC4-4A51-A35D-75886BEF7FEAQ36648170-7F2D7528-3CBB-4738-A86D-9589F8DAAACDQ36885806-4EB080F2-0D11-4D0C-9356-9CAAF0403F0FQ37347202-05B54B92-2440-4071-9802-906D780D5A4BQ37502129-0137BA32-94F2-4FA9-A62C-CB43628871C7Q37671206-B3021CBB-1541-4A23-8F1F-DDB222430B7BQ37722933-36D6BD96-E68D-4156-9650-F14886B48526Q38085702-CDBF9F38-5EB8-4133-ABC2-646A8073568BQ38136113-7219F8C9-800B-4139-93B5-73618B0420A2Q38167670-937CE753-8662-4F26-B3CF-30D61B8968EEQ38804461-AD7C0D24-9364-438D-8727-908D855B97C8Q39255830-CCB0E900-EF05-4ACD-8749-F87EFB5A88BEQ40542661-F4302FE4-2AAB-4E3D-9E4E-CABA4BB30642Q40637231-BFA87F46-D829-40B9-8A31-6CE46F430E4DQ45797554-DEADCFF0-D501-47B3-982D-EBAB5F2B7015Q46977102-2CE31E1B-5185-44F4-B421-EF12CDE83EF0Q47120314-91042B7F-9EBE-4A99-9D94-C4CA5D7C604FQ47575429-05C1B9E7-902B-49C3-AF47-2C41F54DD49FQ48182641-5F740D50-7710-4902-905D-49F94B026C79Q48415729-DA4ED84A-329C-43E5-9310-D5D340FB78D6Q50989612-50735F0E-16E6-40BA-A846-D8CCEF457037Q52991408-CD53D232-5392-414F-BBE8-D3B1DC762726Q53363520-8C011DBB-AC3A-4190-AED8-18458D67C6B2
P2860
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
@en
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
@nl
type
label
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
@en
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
@nl
prefLabel
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
@en
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
@nl
P2093
P2860
P356
P1476
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
@en
P2093
Andreas Tomaschitz
Astrid Fahrleitner-Pammer
Christiane Drechsler
Eberhard Ritz
Jörg H Horina
Katharina Kienreich
Michael Ofner
Stefan Pilz
Thomas R Pieber
P2860
P356
10.1093/CVR/CVS092
P577
2012-02-13T00:00:00Z